Pilson RS - Search Results

1

Purification and characterization of human recombinant IgE-Fc fragments that bind to the human high affinity IgE receptor.

Basu M, Hakimi J, Dharm E, Kondas JA, Tsien WH, Pilson RS, Lin P, Gilfillan A, Haring P, Braswell EH, et al. Basu M, et al. Among authors: pilson rs. J Biol Chem. 1993 Jun 25;268(18):13118-27. J Biol Chem. 1993. PMID: 7685756 Free article.

2

Bispecific humanized anti-IL-2 receptor alpha beta antibodies inhibitory for both IL-2- and IL-15-mediated proliferation.

Pilson RS, Levin W, Desai B, Reik LM, Lin P, Korkmaz-Duffy E, Campbell E, Tso JY, Kerwin JA, Hakimi J. Pilson RS, et al. J Immunol. 1997 Aug 1;159(3):1543-56. J Immunol. 1997. PMID: 9233654

3

Reduced immunogenicity and improved pharmacokinetics of humanized anti-Tac in cynomolgus monkeys.

Hakimi J, Chizzonite R, Luke DR, Familletti PC, Bailon P, Kondas JA, Pilson RS, Lin P, Weber DV, Spence C, et al. Hakimi J, et al. Among authors: pilson rs. J Immunol. 1991 Aug 15;147(4):1352-9. J Immunol. 1991. PMID: 1869828

4

Humanized antibodies against the alpha-chain of the IL-2 receptor and against the beta-chain shared by the IL-2 and IL-15 receptors in a monkey uveitis model of autoimmune diseases.

Guex-Crosier Y, Raber J, Chan CC, Kriete MS, Benichou J, Pilson RS, Kerwin JA, Waldmann TA, Hakimi J, Roberge FG. Guex-Crosier Y, et al. Among authors: pilson rs. J Immunol. 1997 Jan 1;158(1):452-8. J Immunol. 1997. PMID: 8977222

5

Genetic variation in UGT1A1 typical of Gilbert syndrome is associated with unconjugated hyperbilirubinemia in patients receiving tocilizumab.

Lee JS, Wang J, Martin M, Germer S, Kenwright A, Benayed R, Spleiss O, Platt A, Pilson R, Hemmings A, Weinblatt ME, Kaplowitz N, Krasnow J. Lee JS, et al. Pharmacogenet Genomics. 2011 Jul;21(7):365-74. doi: 10.1097/FPC.0b013e32834592fe. Pharmacogenet Genomics. 2011. PMID: 21412181

6

Longterm safety and efficacy of tocilizumab in patients with rheumatoid arthritis: a cumulative analysis of up to 4.6 years of exposure.

Genovese MC, Rubbert-Roth A, Smolen JS, Kremer J, Khraishi M, Gómez-Reino J, Sebba A, Pilson R, Williams S, Van Vollenhoven R. Genovese MC, et al. J Rheumatol. 2013 Jun;40(6):768-80. doi: 10.3899/jrheum.120687. Epub 2013 Mar 1. J Rheumatol. 2013. PMID: 23457383 Clinical Trial.

7

Long-term efficacy and safety of twice-daily saquinavir soft gelatin capsules (SGC), with or without nelfinavir, and three times daily saquinavir-SGC, in triple combination therapy for HIV infection: 100-week follow-up.

Greenberg RN, Feinberg J, Goodrich J, Pilson RS, Siemon-Hryczyk P. Greenberg RN, et al. Among authors: pilson rs. Antivir Ther. 2003 Feb;8(1):37-42. Antivir Ther. 2003. PMID: 12713062 Clinical Trial.

8

Efficacy and safety of twice-daily versus three-times daily saquinavir soft gelatin capsules as part of triple combination therapy for HIV-1 infection.

Wheat LJ, Farthing C, Cohen C, Pierone G, Lalezari J, Pilson RS, Siemon-Hryczyk P; TIDBID (NR15520/M61018) study team. Wheat LJ, et al. Among authors: pilson rs. Antivir Ther. 2002 Sep;7(3):199-209. Antivir Ther. 2002. PMID: 12487388 Clinical Trial.

9

Challenges of antiretroviral treatment in transient and drug-using populations: the SUN study.

Sension MG, Farthing C, Shaffer AG, Graham E, Siemon-Hryczyk P, Pilson RS. Sension MG, et al. Among authors: pilson rs. AIDS Patient Care STDS. 2001 Mar;15(3):129-36. doi: 10.1089/108729101750123580. AIDS Patient Care STDS. 2001. PMID: 11313025 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters